NCT05117177
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05117177
Title New Formulation Study of Inupadenant (EOS100850) in Patients With Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors iTeos Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | BEL

Facility Status City State Zip Country Details
GZA Ziekenhuizen Wilrijk Antwerpen 2610 Belgium Details
Cliniques Universitaires St-Luc Brussels Brussels Capital 1200 Belgium Details
University Hospital Ghent Ghent Ghent 9000 Belgium Details
Institut Jules Bordet Anderlecht 1070 Belgium Details
Royal Marsden NHS Foundation Trust Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field